MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$8,491K
EPS
-$0.95
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
4,897
4,779
4,877*
5,370
General and administrative
3,797
5,091
4,828*
3,881
Total operating expenses
8,694
9,870
9,704
9,251
Operating loss
-8,694
-9,870
-9,704*
-9,251
Impairment charge on investment in equity securities
-
-
0*
0
Interest income
227
309
555*
570
Other expense, net
-24
-28
53*
-11
Loss before income taxes
-8,491
-9,589
-9,097*
-8,692
Income tax benefit
0
0
0*
0
Net loss
-8,491
-9,589
-9,097
-8,692
Basic EPS
-0.95
-1.11
0.039
-0.07
Diluted EPS
-0.95
-1.11
0.039
-0.07
Basic Average Shares
8,908,511
8,622,289
-232,507,886
129,171,424
Diluted Average Shares
8,908,511
8,622,289
-232,507,886
129,171,424
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
ATOS Income Statement Sankey Diagram
Sankey diagram visualizing ATOS income statement for the period
Net loss
-$8,491K
(-0.81%↓ Y/Y)
Loss before income
taxes
-$8,491K
(-0.81%↓ Y/Y)
Interest income
$227K
(-64.81%↓ Y/Y)
Operating loss
-$8,694K
(3.83%↑ Y/Y)
Other expense, net
-$24K
(14.29%↑ Y/Y)
Total operating
expenses
$8,694K
(-3.83%↓ Y/Y)
Research and development
$4,897K
(-11.00%↓ Y/Y)
General and
administrative
$3,797K
(7.32%↑ Y/Y)
Buy us a coffee
ATOSSA THERAPEUTICS, INC. (ATOS)
ATOSSA THERAPEUTICS, INC. (ATOS)